RJT
RGEN icon

Raymond James Trust’s Repligen RGEN Stock Holding History

Raymond James Trust’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$409K Buy
2,750
+475
+21% +$68.1K 0.01% 879
2024
Q2 		$287K Sell
2,275
-45
-2% -$7.05K 0.01% 1003
2024
Q1 		$427K Buy
2,320
+323
+16% +$61.5K 0.01% 792
2023
Q4 		$359K Sell
1,997
-58
-3% -$9.03K 0.01% 841
2023
Q3 		$327K Buy
2,055
+5
+0.2% +$817 0.01% 828
2023
Q2 		$290K Buy
2,050
+187
+10% +$30K 0.01% 907
2023
Q1 		$314K Sell
1,863
-51
-3% -$9.1K 0.01% 846
2022
Q4 		$324K Sell
1,914
-455
-19% -$82.5K 0.01% 784
2022
Q3 		$444K Buy
2,369
+54
+2% +$11.4K 0.02% 622
2022
Q2 		$376K Sell
2,315
-16
-0.7% -$2.53K 0.01% 690
2022
Q1 		$438K Buy
2,331
+634
+37% +$120K 0.01% 689
2021
Q4 		$450K Sell
1,697
-113
-6% -$30.4K 0.01% 696
2021
Q3 		$523K Buy
1,810
+160
+10% +$41K 0.02% 602
2021
Q2 		$329K Sell
1,650
-15
-0.9% -$2.91K 0.01% 820
2021
Q1 		$324K Buy
1,665
+558
+50% +$114K 0.01% 791
2020
Q4 		$212K Buy
+1,107
New +$201K 0.01% 951

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Trust's RGEN Position: Q3 2024 in Review

Raymond James Trust increased its Repligen (RGEN) stake by 21% in Q3 2024, buying an estimated $68.1K and bringing the position to 2,750 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #879.

Raymond James Trust first reported a position in RGEN in Q4 2020 and has held it in 16 quarters since. The position peaked at $523K in Q3 2021. 443 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Raymond James Trust held 2,750 shares of Repligen worth $409K as of Q3 2024.
  • Raymond James Trust bought 475 Repligen shares in Q3 2024, an estimated $68.1K.
  • Repligen made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #879 holding.
  • Raymond James Trust first reported a position in Repligen in Q4 2020 and has held it in 16 quarters since.
  • Raymond James Trust's Repligen position peaked at $523K in Q3 2021.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.